These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions. Letts LG; McFarlane C; Piechuta H; Ford-Hutchinson AW Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1007-11. PubMed ID: 2960143 [No Abstract] [Full Text] [Related]
3. Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity. Musser JH; Kubrak DM; Chang J; Lewis AJ Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():536-9. PubMed ID: 2959109 [No Abstract] [Full Text] [Related]
4. 5-Lipoxygenase inhibitors and allergic conjunctivitis reactions in the guinea-pig. Garceau D; Ford-Hutchinson AW; Charleson S Eur J Pharmacol; 1987 Nov; 143(1):1-7. PubMed ID: 2826183 [TBL] [Abstract][Full Text] [Related]
5. Preferential inhibition of 5-lipoxygenase activity by manoalide. De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081 [TBL] [Abstract][Full Text] [Related]
6. The regulation of 5-lipoxygenase activity in rat basophilic leukemia cells. Wong A; Hwang SM; Cook MN Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():28-34. PubMed ID: 2169181 [No Abstract] [Full Text] [Related]
7. The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions. Ford-Hutchinson AW Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():507-10. PubMed ID: 2546393 [No Abstract] [Full Text] [Related]
9. New lipoxygenase inhibitors isolated from Chinese plants. Development of new anti-allergic drugs. Murota S; Koshihara Y Drugs Exp Clin Res; 1985; 11(9):641-4. PubMed ID: 3880051 [TBL] [Abstract][Full Text] [Related]
10. Manipulations of arachidonic acid metabolism using a 5-lipoxygenase inhibitor in transfusion-induced immunosuppression. Heyd TJ; Perez RV; Trocki O; Alexander JW Transplant Proc; 1988 Dec; 20(6):1186-9. PubMed ID: 3144072 [No Abstract] [Full Text] [Related]
12. Improved rat cardiac allograft survival with nonsteroidal pharmacologic agents related to eicosanoids. Foegh ML; Khirabadi BS; Ramwell PW Transplant Proc; 1987 Feb; 19(1 Pt 2):1297-300. PubMed ID: 3547861 [No Abstract] [Full Text] [Related]
13. Development of 5-lipoxygenase inhibitor. Toda M; Nakai H; Sakuyama S; Arai Y; Kaneko S; Ohno H; Okegawa T Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():768-70. PubMed ID: 2960188 [No Abstract] [Full Text] [Related]
14. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965 [TBL] [Abstract][Full Text] [Related]
15. In vivo generation of 5-lipoxygenase products in frogs and toads. Green FA Biochem Biophys Res Commun; 1987 Nov; 148(3):1533-9. PubMed ID: 2825691 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of arachidonate 5-lipoxygenase metabolites in human polymorphonuclear leukocytes by reverse-phase high-performance liquid chromatography. Hamasaki T Hiroshima J Med Sci; 1986 Jun; 35(2):99-103. PubMed ID: 3021690 [No Abstract] [Full Text] [Related]
17. [Selective inhibitory effects of flufenamic acid on metabolic pathways of arachidonate 5-lipoxygenase and cyclooxygenase]. Li NY Sheng Li Ke Xue Jin Zhan; 1989 Oct; 20(4):357-9. PubMed ID: 2561227 [No Abstract] [Full Text] [Related]
18. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis]. Lototskaia LS; Naĭdenova IIu; Il'iasheva LM; Poda GI; Kornilov AI Farmakol Toksikol; 1989; 52(2):59-62. PubMed ID: 2501105 [TBL] [Abstract][Full Text] [Related]